Ignite Creation Date:
2025-12-24 @ 4:46 PM
Ignite Modification Date:
2026-01-05 @ 5:12 PM
Study NCT ID:
NCT05487950
Status:
NOT_YET_RECRUITING
Last Update Posted:
2023-03-28
First Post:
2022-08-02
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Rivaroxaban Versus Standard of Care for Patients With Excessive Atrial Ectopy or Short Atrial Runs and High Embolism Risk
Sponsor:
Assistance Publique - Hôpitaux de Paris
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2023-04-05
Start Date Type:
ESTIMATED
Primary Completion Date:
2027-04-05
Primary Completion Date Type:
ESTIMATED
Completion Date:
2027-04-05
Completion Date Type:
ESTIMATED
First Submit Date:
2022-08-02
First Submit QC Date:
None
Study First Post Date:
2022-08-04
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2023-03-24
Last Update Post Date:
2023-03-28
Last Update Post Date Type:
ACTUAL